Changyu Y. Pan
No. 28 Fu Xing Road
Beijing, 100853, China
Beijing, 100853, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Optic atrophy in a patient with axonal Charcot-Marie-Tooth disease 2A2A due to MFN2 gene mutations
Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
Published: May 08, 2023
Characteristics of Newly Diagnosed Type 2 Diabetes in Chinese Older Adults: A National Prospective Cohort Study.
Journal: Journal of diabetes research
Published: August 14, 2019
Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: A cross-sectional study.
Journal: Journal of diabetes investigation
Published: April 30, 2019
Evaluation of effectiveness of treatment paradigm for newly diagnosed type 2 diabetes patients in Chin: A nationwide prospective cohort study.
Journal: Journal of diabetes investigation
Published: March 14, 2019
The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study.
Journal: Scientific reports
Published: October 22, 2018
Clinical value of tumor size in the evaluation of adrenal incidentalomas
Journal: Zhonghua yi xue za zhi
Published: November 17, 2017
Surgery versus conservative management for subclinical Cushing's syndrome in adrenal incidentalomas
Journal: Zhonghua yi xue za zhi
Published: October 31, 2017
The efficacy and safety of insulin degludec versus insulin glargine in insulin-naive subjects with type 2 diabetes: results of a Chinese cohort from a multinational randomized controlled trial
Journal: Zhonghua nei ke za zhi
Published: September 06, 2017
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
Journal: The lancet. Diabetes & endocrinology
Published: August 07, 2017
Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double-blind, active-controlled, phase 3 trial.
Journal: Diabetes, obesity & metabolism
Published: June 26, 2017
Last Updated: 09/26/2026